Leptin is an adipocyte hormone that provides the central nervous system as well as peripheral organs with a signal of nutritional status. Leptin has important effects in the regulation of endocrine function. Leptin treatment of starved rodents corrects the effects of starvation or immaturity on the pituitary-adrenal, pituitary-gonadal, and pituitary-thyroid endocrine axes. However, there are important differences in metabolism and leptin biology of human leptin. The results obtained by studies of leptin treatment of non-leptin treatment of non-leptin deficient subjects are confounded by the pulsatile and highly variable endogenous leptin production, as well as by the fact that the transport of leptin into the brain is saturable. Moreover, leptin has not been widely available for endocrine investigation. The P.I. of this application has successfully worked with the only three adult individuals who have been identified anywhere in the world with a functional leptin gene mutation, of Mendelian recessive inheritance. Those patients are members of a large, extended, and highly consanguineous pedigree. They are morbidity obese and present with endocrine dysfunction. To test the hypothesis that leptin contributes to regulation of the minute-to-minute dynamics of human endocrine function, we propose a series of prospective, longitudinal, rapid-sampled 24-h endocrine studies during the course of leptin replacement therapy in those patients. The confirmation of our working hypotheses has two implications. For the understanding of biology, it will indicate that leptin, the product of a disperse mass of peripheral fat cells, contributes to regulate a key function of t he central nervous system which is endocrine homeostasis. Additionally, the proposed studies may identify novel sites of leptin action that may represent novel therapeutic targets in the treatment of human disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
1R01DK058851-01
Application #
6256413
Study Section
Endocrinology Study Section (END)
Program Officer
Smith, Philip F
Project Start
2000-12-15
Project End
2002-11-30
Budget Start
2000-12-15
Budget End
2001-11-30
Support Year
1
Fiscal Year
2001
Total Cost
$379,983
Indirect Cost
Name
University of California Los Angeles
Department
Psychiatry
Type
Schools of Medicine
DUNS #
119132785
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Paz-Filho, Gilberto; Mastronardi, Claudio A; Licinio, Julio (2015) Leptin treatment: facts and expectations. Metabolism 64:146-56
Licinio, J; Negrao, A B; Wong, M-L (2014) Plasma leptin concentrations are highly correlated to emotional states throughout the day. Transl Psychiatry 4:e475
Berman, Steven M; Paz-Filho, Gilberto; Wong, Ma-Li et al. (2013) Effects of leptin deficiency and replacement on cerebellar response to food-related cues. Cerebellum 12:59-67
Ishibashi, K; Berman, S M; Paz-Filho, G et al. (2012) Dopamine D2/D3 receptor availability in genetically leptin-deficient patients after long-term leptin replacement. Mol Psychiatry 17:352-3
London, Edythe D; Berman, Steven M; Chakrapani, Shruthi et al. (2011) Short-term plasticity of gray matter associated with leptin deficiency and replacement. J Clin Endocrinol Metab 96:E1212-20
Paz-Filho, Gilberto; Mastronardi, Claudio; Delibasi, Tuncay et al. (2010) Congenital leptin deficiency: diagnosis and effects of leptin replacement therapy. Arq Bras Endocrinol Metabol 54:690-7
Galgani, Jose E; Greenway, Frank L; Caglayan, Sinan et al. (2010) Leptin replacement prevents weight loss-induced metabolic adaptation in congenital leptin-deficient patients. J Clin Endocrinol Metab 95:851-5
Paz-Filho, G; Wong, M-L; Licinio, J (2010) The procognitive effects of leptin in the brain and their clinical implications. Int J Clin Pract 64:1808-12
Paz-Filho, Gilberto Jorge; Delibasi, Tuncay; Erol, Halil Kutlu et al. (2009) Cellular immunity before and after leptin replacement therapy. J Pediatr Endocrinol Metab 22:1069-74
Paz-Filho, G J; Andrews, D; Esposito, K et al. (2009) Effects of leptin replacement on risk factors for cardiovascular disease in genetically leptin-deficient subjects. Horm Metab Res 41:164-7

Showing the most recent 10 out of 34 publications